GB9311281D0
(en)
*
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
Novel composition of matter
|
US5698711A
(en)
|
1991-01-28 |
1997-12-16 |
Rhone-Poulenc Rorer Limited |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
|
GB9212673D0
(en)
*
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
US5679696A
(en)
*
|
1992-07-28 |
1997-10-21 |
Rhone-Poulenc Rorer Limited |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
|
GB9222253D0
(en)
*
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
KR950704228A
(ko)
*
|
1992-12-02 |
1995-11-17 |
알렌 제이. 스피겔 |
선택적 포스포디에스테르가수분해효소 iv형(pde_iv) 저해제로서의 카테콜 디에테르(catecol diethers as selective pde_iv inhibitors)
|
US5814651A
(en)
*
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
US5622977A
(en)
*
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
TW263495B
(es)
*
|
1992-12-23 |
1995-11-21 |
Celltech Ltd |
|
GB9226830D0
(en)
*
|
1992-12-23 |
1993-02-17 |
Celltech Ltd |
Chemical compounds
|
GB9304919D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
DK0710109T3
(da)
*
|
1993-06-18 |
2005-01-03 |
Smithkline Beecham Corp |
Fremgangsmåde til identifikation af en PDE IV inhibitor
|
DK0711282T3
(da)
|
1993-07-28 |
2002-09-16 |
Aventis Pharma Ltd |
Forbindelser som PDE IV og TNF inhibitorer
|
US5665754A
(en)
*
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
AU687452B2
(en)
*
|
1993-11-26 |
1998-02-26 |
Pfizer Inc. |
Isoxazoline compounds as antiinflammatory agents
|
DK0730587T3
(da)
*
|
1993-11-26 |
2000-04-10 |
Pfizer |
3-phenyl-2-isoxazoliner som anti-inflammatoriske midler
|
EP0738268B1
(en)
*
|
1993-12-22 |
2004-03-03 |
Celltech R&D Limited |
Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
|
GB9326173D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
CA2143143A1
(en)
*
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
CN1143363A
(zh)
*
|
1994-03-09 |
1997-02-19 |
辉瑞大药厂 |
作为tnf释放抑制剂的异噁唑啉化合物
|
WO1995024192A1
(en)
*
|
1994-03-09 |
1995-09-14 |
Pfizer Inc. |
Isoxazoline compounds as 5-lipoxygenase inhibitors
|
US5672622A
(en)
*
|
1994-04-21 |
1997-09-30 |
Berlex Laboratories, Inc. |
Treatment of multiple sclerosis
|
EP1380291A1
(en)
*
|
1994-04-21 |
2004-01-14 |
Schering Aktiengesellschaft |
PDE IV inhibitors for treating multiple sclerosis
|
DK0758233T3
(da)
*
|
1994-04-21 |
2004-03-22 |
Schering Ag |
PDE IV-inhibitorer til behandling af multipel sklerose
|
US6060501A
(en)
*
|
1994-06-02 |
2000-05-09 |
Schering Aktiengesellschaft |
Combined treatment of multiple sclerosis
|
US5998428A
(en)
*
|
1995-05-31 |
1999-12-07 |
Smithkline Beecham Corporation |
Compounds and methods for treating PDE IV-related diseases
|
US5786354A
(en)
*
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
GB9412571D0
(en)
*
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412573D0
(en)
*
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412672D0
(en)
*
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
US5591776A
(en)
*
|
1994-06-24 |
1997-01-07 |
Euro-Celtique, S.A. |
Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
|
US5563143A
(en)
*
|
1994-09-21 |
1996-10-08 |
Pfizer Inc. |
Catechol diether compounds as inhibitors of TNF release
|
US5665737B1
(en)
*
|
1994-10-12 |
1999-02-16 |
Euro Celtique Sa |
Substituted benzoxazoles
|
EP0814809B1
(en)
*
|
1994-12-13 |
2003-08-13 |
Euroceltique S.A. |
Aryl thioxanthines
|
ZA961081B
(en)
*
|
1995-02-10 |
1996-10-15 |
Schering Ag |
Pharmaceutical preparations for tnf inhibition
|
US6268373B1
(en)
|
1995-06-07 |
2001-07-31 |
Euro-Celtique S.A. |
Trisubstituted thioxanthines
|
US5658940A
(en)
*
|
1995-10-06 |
1997-08-19 |
Celgene Corporation |
Succinimide and maleimide cytokine inhibitors
|
DE19540475A1
(de)
*
|
1995-10-20 |
1997-04-24 |
Schering Ag |
Chirale Methylphenyloxazolidinone
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526246D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526245D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9608435D0
(en)
*
|
1996-04-24 |
1996-06-26 |
Celltech Therapeutics Ltd |
Chemical compounds
|
EA002274B1
(ru)
*
|
1996-06-25 |
2002-02-28 |
Пфайзер Инк. |
Призводные замещенного индазола и их применение в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и фактора некроза опухоли (фно)
|
US5744473A
(en)
*
|
1996-09-16 |
1998-04-28 |
Euro-Celtique, S.A. |
PDE IV inhibitors: "bis-compounds"
|
GB9619284D0
(en)
*
|
1996-09-16 |
1996-10-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9622363D0
(en)
*
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
*
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
EP0946523A1
(en)
|
1996-12-23 |
1999-10-06 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
GB9705361D0
(en)
*
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
KR19980074060A
(ko)
*
|
1997-03-21 |
1998-11-05 |
김윤배 |
신규한 치환된 3,4-디알콕시페닐 유도체
|
GB9713087D0
(en)
*
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9914258D0
(en)
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6680336B2
(en)
|
1999-12-15 |
2004-01-20 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6376489B1
(en)
|
1999-12-23 |
2002-04-23 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6348602B1
(en)
*
|
1999-12-23 |
2002-02-19 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6372777B1
(en)
|
1999-12-23 |
2002-04-16 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
FR2803593B1
(fr)
*
|
2000-01-06 |
2002-02-15 |
Sanofi Synthelabo |
Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
|
US6555572B2
(en)
|
2000-03-16 |
2003-04-29 |
Inflazyme Pharmaceuticals Ltd. |
Benzylated PDE4 inhibitors
|
IT1317049B1
(it)
*
|
2000-06-23 |
2003-05-26 |
Sigma Tau Ind Farmaceuti |
Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
|
WO2002081446A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Daewoong Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
|
WO2002081447A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Daewoong Pharmaceutical Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
|
FR2823748B1
(fr)
*
|
2001-04-20 |
2004-02-20 |
Sanofi Synthelabo |
Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
|
EP1392662B1
(de)
|
2001-05-29 |
2009-01-07 |
Bayer Schering Pharma Aktiengesellschaft |
Cdk inhibitorische pyrimidine, deren herstellung und verwendung als arzneimittel
|
DE60233884D1
(de)
*
|
2001-10-16 |
2009-11-12 |
Memory Pharmaceutical Corp |
4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-derivate als pde-4-hemmer zur behandlung von neurologischen syndromen
|
WO2004011429A1
(ja)
*
|
2002-07-26 |
2004-02-05 |
Nihon Nohyaku Co., Ltd. |
新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法
|
JP2004107323A
(ja)
*
|
2002-07-26 |
2004-04-08 |
Nippon Nohyaku Co Ltd |
新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法
|
KR100875318B1
(ko)
|
2002-11-26 |
2008-12-22 |
화이자 프로덕츠 인크. |
Ppar 활성화 인자로 사용하기 위한 페닐 치환된피페리딘 화합물
|
WO2004094375A2
(en)
*
|
2003-04-16 |
2004-11-04 |
Memory Pharmaceuticals Corporation |
4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
CN1809559B
(zh)
|
2003-04-18 |
2010-06-02 |
记忆药物公司 |
作为磷酸二酯酶4抑制剂的吡唑衍生物
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
CA2584169A1
(en)
*
|
2004-10-13 |
2006-04-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Remedies/preventives for chronic skin disease
|
WO2006041120A1
(ja)
*
|
2004-10-13 |
2006-04-20 |
Kyowa Hakko Kogyo Co., Ltd. |
医薬組成物
|
EP1799673A1
(en)
|
2004-10-15 |
2007-06-27 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
EP1802615A1
(en)
|
2004-10-20 |
2007-07-04 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
GB0424284D0
(en)
|
2004-11-02 |
2004-12-01 |
Novartis Ag |
Organic compounds
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
US7517870B2
(en)
|
2004-12-03 |
2009-04-14 |
Fondazione Telethon |
Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
EP2532679B1
(en)
|
2005-10-21 |
2017-04-12 |
Novartis AG |
Human antibodies against il13 and therapeutic uses
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
GB0601951D0
(en)
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
SI2013211T1
(sl)
|
2006-04-21 |
2012-07-31 |
Novartis Ag |
Purinski derivati za uporabo kot agonisti receptorja adenozina A A
|
CN101516885A
(zh)
|
2006-09-29 |
2009-08-26 |
诺瓦提斯公司 |
作为pi3k脂质激酶抑制剂的吡唑并嘧啶类化合物
|
WO2008052734A1
(en)
|
2006-10-30 |
2008-05-08 |
Novartis Ag |
Heterocyclic compounds as antiinflammatory agents
|
PT2104535E
(pt)
|
2007-01-10 |
2011-03-31 |
Irm Llc |
Compostos e composições como inibidores da protease de activação de canal
|
BRPI0811562A2
(pt)
|
2007-05-07 |
2014-12-09 |
Novartis Ag |
Compostos orgânicos
|
ES2602331T3
(es)
|
2007-12-10 |
2017-02-20 |
Novartis Ag |
Pirazin-carboxamidas de tipo amilorida como bloqueantes de ENaC
|
EA201001129A1
(ru)
|
2008-01-11 |
2011-02-28 |
Новартис Аг |
Пиримидины в качестве ингибиторов киназы
|
ES2535736T3
(es)
|
2008-06-10 |
2015-05-14 |
Novartis Ag |
Derivados de pirazina como bloqueadores de los canales de sodio epitelial
|
ES2396023T3
(es)
|
2009-01-29 |
2013-02-18 |
Novartis Ag |
Bencimidazoles sustituidos para el tratamiento de astrocitomas
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
MX2012001838A
(es)
|
2009-08-12 |
2012-02-29 |
Novartis Ag |
Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion.
|
AU2010284254B2
(en)
|
2009-08-17 |
2015-09-17 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
JP5775871B2
(ja)
|
2009-08-20 |
2015-09-09 |
ノバルティス アーゲー |
ヘテロ環式オキシム化合物
|
US20110098311A1
(en)
|
2009-10-22 |
2011-04-28 |
Vertex Pharmaceuticals Incorported |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
US8637516B2
(en)
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
JP2014505088A
(ja)
|
2011-02-10 |
2014-02-27 |
ノバルティス アーゲー |
C−METチロシンキナーゼ阻害剤としての[1,2,4]トリアゾロ[4,3−b]ピリダジン化合物
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
CN103492384B
(zh)
|
2011-02-25 |
2016-05-11 |
诺华股份有限公司 |
作为trk抑制剂的化合物和组合物
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
BR112014006223A8
(pt)
|
2011-09-15 |
2018-01-09 |
Novartis Ag |
3-(quinolin-6-iltio)-[1,2,4-triazol[4,3-a] piradinas 6-substituídas, seus usos, composições farmacêuticas, e combinação
|
JP5886433B2
(ja)
|
2011-09-16 |
2016-03-16 |
ノバルティス アーゲー |
嚢胞性線維症処置のためのヘテロ環式化合物
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
JP6165733B2
(ja)
|
2011-09-16 |
2017-07-19 |
ノバルティス アーゲー |
N−置換ヘテロシクリルカルボキサミド類
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
US20130209543A1
(en)
|
2011-11-23 |
2013-08-15 |
Intellikine Llc |
Enhanced treatment regimens using mtor inhibitors
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
CN104245701A
(zh)
|
2012-04-03 |
2014-12-24 |
诺华有限公司 |
有酪氨酸激酶抑制剂的组合产品和其应用
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
EP2968340A4
(en)
|
2013-03-15 |
2016-08-10 |
Intellikine Llc |
COMBINING KINASE INHIBITORS AND USES THEREOF
|
TW201605450A
(zh)
|
2013-12-03 |
2016-02-16 |
諾華公司 |
Mdm2抑制劑與BRAF抑制劑之組合及其用途
|
US10112926B2
(en)
|
2014-04-24 |
2018-10-30 |
Novartis Ag |
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
|
AU2014391608A1
(en)
|
2014-04-24 |
2016-10-27 |
Novartis Ag |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
EP3134395B1
(en)
|
2014-04-24 |
2018-01-31 |
Novartis AG |
Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
CA2954862A1
(en)
|
2014-07-31 |
2016-02-04 |
Novartis Ag |
Combination therapy
|
US20200383960A1
(en)
|
2019-06-10 |
2020-12-10 |
Novartis Ag |
Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis
|
JP2022547427A
(ja)
|
2019-08-28 |
2022-11-14 |
ノバルティス アーゲー |
置換1,3-フェニルヘテロアリール誘導体及び疾患の治療におけるその使用
|
CN114558002A
(zh)
*
|
2022-03-15 |
2022-05-31 |
四川轻化工大学 |
化合物在制备治疗肿瘤药物中的应用
|